In the BioHarmony Drug Report Database
Tavaborole
Kerydin (tavaborole) is a small molecule pharmaceutical. Tavaborole was first approved as Kerydin on 2014-07-07. It is used to treat mycoses and onychomycosis in the USA.
Trade Name
|
Kerydin |
|---|---|
Common Name
|
tavaborole |
ChEMBL ID
|
CHEMBL443052 |
Indication
|
mycoses, onychomycosis |
Drug Class
|
Boroles, boron compounds |
Image (chem structure or protein)